Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
20.72
0.00 (0.00%)
Nov 26, 2025, 4:00 PM EST - Market closed

Quoin Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
1755715-
Upgrade
Market Cap Growth
413.81%10.02%-29.65%-54.69%--
Upgrade
Enterprise Value
14-2-5-421-
Upgrade
Last Close Price
20.7222.77171.68596.409555.01-
Upgrade
PB Ratio
-0.580.860.9323.12-
Upgrade
P/TBV Ratio
-0.610.951.03--
Upgrade
Debt / Equity Ratio
-2.040.320.620.567.19-0.18
Upgrade
Quick Ratio
0.943.362.993.641.640.04
Upgrade
Current Ratio
1.043.573.153.791.790.06
Upgrade
Return on Equity (ROE)
-651.40%-120.55%-132.92%-232.68%--
Upgrade
Return on Assets (ROA)
-99.47%-42.72%-44.03%-48.59%-70.60%-87.18%
Upgrade
Return on Capital (ROIC)
-181.28%-55.88%-56.58%-68.43%--
Upgrade
Return on Capital Employed (ROCE)
-2150.70%-82.70%-109.20%-84.70%-126.80%25.30%
Upgrade
Earnings Yield
-79.20%-168.23%-179.39%-136.30%-141.27%-
Upgrade
Buyback Yield / Dilution
-416.87%-420.43%----
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q